524606 BERLDRG

Beryl Drugs Share Price

 

 

Start SIP in BERLDRG

Start SIP

Performance

  • Low
  • ₹23
  • High
  • ₹23
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹44
  • Open Price₹23
  • Previous Close₹23
  • Volume15

Investment Returns

  • Over 1 Month -3.71%
  • Over 3 Month + 14.75%
  • Over 6 Month + 17.92%
  • Over 1 Year -40.48%

Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!

Invest Now

Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 50.5
  • PEG Ratio
  • -0.8
  • Market Cap Cr
  • 12
  • P/B Ratio
  • 1.2
  • Average True Range
  • 1.69
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.07
  • RSI
  • 49.48
  • MFI
  • 73.61

Beryl Drugs Financials

Beryl Drugs Technicals

EMA & SMA

Current Price
₹23.10
0 (0%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹23.23
  • 50 Day
  • ₹22.98
  • 100 Day
  • ₹22.90
  • 200 Day
  • ₹24.29

Resistance and Support

22.97 Pivot Speed
  • R3 25.57
  • R2 24.66
  • R1 23.88
  • S1 22.19
  • S2 21.28
  • S3 20.50

Beryl Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-09-02 A.G.M.
2025-08-07 Quarterly Results
2025-05-30 Audited Results
2025-02-08 Quarterly Results
2024-11-13 Quarterly Results

Beryl Drugs F&O

Beryl Drugs Shareholding Pattern

26.38%
68.71%
4.91%

About Beryl Drugs

  • NSE Symbol
  • BERLDRG
  • BSE Symbol
  • 524606
  • Managing Director
  • Mr. Sanjay Sethi
  • ISIN
  • INE415H01017

Similar Stocks to Beryl Drugs

Beryl Drugs FAQs

Beryl Drugs share price is ₹23 As on 07 November, 2025 | 11:54

The Market Cap of Beryl Drugs is ₹11.7 Cr As on 07 November, 2025 | 11:54

The P/E ratio of Beryl Drugs is 50.5 As on 07 November, 2025 | 11:54

The PB ratio of Beryl Drugs is 1.2 As on 07 November, 2025 | 11:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23